Major depressive disorder (mdd) Trials in Beijing, China
Conditions / Major depressive disorder (mdd) / Beijing, China
Major depressive disorder (mdd) is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06958692 | A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder | RECRUITING | PHASE3 |
| NCT02395263 | Comparison of Yuxintine With Placebo in Treatment of MDD | UNKNOWN | PHASE2 |
| NCT07193901 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior | RECRUITING | PHASE2 |
| NCT06692361 | Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder | RECRUITING | NA |
| NCT04853407 | A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT02191384 | Comparison of Orcinoside With Placebo in Treatment of MDD | COMPLETED | PHASE2 |
| NCT07253207 | Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00368303 | A Local Register Study For Major Depression Of Paroxetine Controlled Release | COMPLETED | PHASE3 |
| NCT02380066 | Comparison of Anyu Peibo With Placebo in Treatment of MDD | COMPLETED | PHASE2 |
| NCT06796868 | A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder | COMPLETED | PHASE2 |